We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

14 hedge funds and large institutions have $4.83M invested in Virtus Biotech ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.12% more ownership

Funds ownership: 26.87% → 27.99% (+1.1%)

4% more capital invested

Capital invested by funds: $4.63M → $4.83M (+$193K)

18% less funds holding

Funds holding: 17 → 14 (-3)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$1.45M
2
Morgan Stanley
Morgan Stanley
New York
+$303K
3
LPL Financial
LPL Financial
California
+$36.2K

Top Sellers

Rank Fund Capital Flow
1
Rockefeller Capital Management
Rockefeller Capital Management
New York
-$1.19M
2
CCM
Coldstream Capital Management
Washington
-$211K
3
Stifel Financial
Stifel Financial
Missouri
-$67.9K
4
UBS Group
UBS Group
Switzerland
-$44.9K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$33.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$1.8M +$1.45M +28,919 +381%
Morgan Stanley
2
Morgan Stanley
New York
$862K +$303K +6,040 +53%
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$770K -$33.6K -669 -4%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$629K -$14.8K -295 -2%
LPL Financial
5
LPL Financial
California
$268K +$36.2K +722 +15%
Stifel Financial
6
Stifel Financial
Missouri
$217K -$67.9K -1,353 -23%
MIFH
7
Migdal Insurance & Financial Holdings
Israel
$136K – – –
Osaic Holdings
8
Osaic Holdings
Arizona
$61K – – –
Carson Wealth (CWM LLC)
9
Carson Wealth (CWM LLC)
Nebraska
$27K – – –
DSC
10
Duncker Streett & Co
Missouri
$26.3K – – –
Northwestern Mutual Wealth Management
11
Northwestern Mutual Wealth Management
Wisconsin
$10.2K – – –
FWM
12
Focused Wealth Management
New York
$9.86K – – –
UBS Group
13
UBS Group
Switzerland
$8.62K -$44.9K -894 -84%
BAM
14
Belpointe Asset Management
Nevada
$2.27K – – –
Rockefeller Capital Management
15
Rockefeller Capital Management
New York
– -$1.19M -24,073 Closed
CCM
16
Coldstream Capital Management
Washington
– -$211K -4,285 Closed
MCC
17
Money Concepts Capital
Florida
– -$9.51K -193 Closed

BBP Hedge Fund Activity: Q1 2023 in Review

14 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2023, worth a combined $4.83M — up 4.2% from $4.63M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BBP and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Citadel Advisors, adding an estimated $1.45M. The largest seller was Rockefeller Capital Management, exiting entirely with an estimated $1.19M sold.

  • 14 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2023, down from 17 in Q4 2022.
  • Funds reported $4.83M of Virtus Biotech ETF stock for Q1 2023, up 4.2% quarter-over-quarter.
  • 0 funds opened new Virtus Biotech ETF positions in Q1 2023 and 3 closed out, a net change of -3 holders.
  • The largest Virtus Biotech ETF buyer in Q1 2023 was Citadel Advisors, an estimated $1.45M added.
  • The largest Virtus Biotech ETF seller in Q1 2023 was Rockefeller Capital Management, an estimated $1.19M sold.

Based on aggregated 13F filings for Q1 2023.